“Evidence-based prevention strategies, including increasing hepatitis B vaccination coverage, testing and linkage to care, and implementing educatio... More »
Clinical trial results for direct-acting antivirals against hepatitis C virus (HCV) may have limited generalizability for patients coinfected with HIV... More »
Annual fecal immunochemical testing (FIT) for colorectal cancer screening demonstrated slightly decreased but steady sensitivity and predictive values... More »
Payers’ fail-first policies pose special concerns for clinicians treating with biologic therapies. Until these become cheaper, navigating them will ... More »
A biomarker for which a screening test is already available – lack of CDX2 expression – appears to identify the approximately 20% of stage II and ... More »
The new drug eluxadoline improved symptoms of irritable bowel syndrome with diarrhea in two manufacturer-sponsored phase III clinical trials involving... More »
Everolimus improves outcomes in patients with advanced, progressive neuroendocrine tumors of gastrointestinal (GI) or unknown origin regardless of pri... More »
The radiolabeled somatostatin analog 177Lu-Dotatate is efficacious and safe in patients with previously treated advanced midgut neuroendocrine tumors,... More »
Fecal microbiota transplantation using frozen-then-thawed fecal material proved noninferior to that using fresh material for treating recurrent or ref... More »
The use of proton pump inhibitors increased the risk of chronic kidney disease by 20%-50%, said the authors of two large population-based cohort analy... More »
